Skip To Content
Get Our Newsletter
JEWISH. INDEPENDENT. NONPROFIT.

Support the Forward

Funded by readers like you DonateSubscribe
Fast Forward

Donald Trump Didn’t Want Israel Exporting Medical Marijuana. So It Won’t.

JERUSALEM (JTA) — Israel has halted a plan to export medical marijuana for fear of upsetting President Donald Trump.

Prime Minister Benjamin Netanyahu ordered the plan to be frozen early this week despite support from the Health, Agriculture and Finance ministries, Hadashot news reported Wednesday evening.

Netanyahu told the heads of the ministries he ordered the freeze after receiving a call about the issue of exporting marijuana from Trump, who is against its legalization. The prime minister made it clear that he did not want Israel to be a pioneer in the export of medical marijuana in order not to  anger the U.S. president, according to the report. Canada is the only country that has approved the export of medical marijuana.

A Finance Ministry representative reportedly suggested that Israel could avoiding export to the United States in order to appease Trump, leading Netanyahu to respond that would not necessarily serve Israeli interests to go against the Trump administration’s policy.

A government committee had determined that the export of cannabis would bring between 285 million to $1.14 billion a year to the Israeli economy, according to the report.

An estimated 50 Israeli medical marijuana companies work in cultivating plants or producing delivery devices for the drug, according to Reuters.

Israeli kibbutzes see the export of medical marijuana as a way to revitalize their communities.

Engage

  • SHARE YOUR FEEDBACK

  • UPCOMING EVENT

    NY-12 Candidate Forum

    THE TEMPLE EMANU-EL STREICKER CENTER and Virtual

    Aug 10, 2022

    7 pm ET · 

    Will the last Jew left in New York’s congressional delegation be reelected? Will New York’s senior congresswoman receive another term? Or will one of the newcomers upend Manhattan politics?

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free under an Attribution-Non Commercial-No Derivatives Creative Commons license as long as you follow our republishing guidelines, which require that you credit the Foward and retain our pixel. See our full guidelines for more information.

To republish, copy the HTML, which includes our tracking pixel, all paragraph styles and hyperlinks, the author byline, images, and credit to the Foward. Have questions? Please email us at editorial@forward.com.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.